"Andres Poveda, MD Initia Oncology Hospital Quironsalud Valencia, Spain 5 Live #ASCO20"
4:57
Key Insights on Olaparib maintenance monotherapy for non-germline BRCA1/2-mutated (non-gBRCAm) platinum-sensitive relapsed ovarian cancer (PSR OC) patients (pts): Phase IIIb OPINION interim analysis.
Key Insights on Olaparib maintenance monotherapy for non-germline BRCA1/2-mutated (non-gBRCAm) platinum-sensitive relapsed ovarian cancer (PSR OC) patients (pts): Phase IIIb OPINION interim analysis.
Gynecologic Malignancies Similar Videos
-
Robert Coleman, MD; Texas Oncology; 5Live #SGO22
6:07
Key Insights from the 2022 Society of Gynecologic Oncology (SGO) Annual Meeting #SGO22
-
Ritu Salani, MD, MBA; David Geffen School of Medicine at UCLA; 5Live; #ASCO2021
4:35
-
Harnessing the Power of Antibody-Drug Conjugates for the Treatment of Hematologic and Solid Cancer: The Promise of Antibody-Drug Conjugates in Gynecologic Malignancies_Bhavana Pothuri, MD
33:38